港股异动 | 锦欣生殖(1951.HK)升逾7%创1年新高 月内累涨超45%
格隆汇11月27日丨锦欣生殖(1951.HK)延续强势行情,月内已涨超45%。现报13.88港元创1年新高价,涨7.1%,暂成交1.86亿港元,总市值337.2亿港元。招银国际日前表示,公司现有医院网络在疫情期间极具挑战性的经营环境下,依然取得了非常好的表现。维持买入评级,目标价提升至15.51港元。预期公司每年完成一到两笔并购交易,包括在中国大陆以及海外的并购交易。此外,预期公司将继续扩大在深圳的运营能力,以进一步提升其在广东市场的领先地位。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.